Chinese Heparin Supplier Posts Strong Trading Debut
Friday, May 7, 2010 - 00:01
in Mathematics & Economics
The shares of Shenzhen Hepalink Pharmaceutical rose 18.3 percent, valuing the company at about $10 billion.
The shares of Shenzhen Hepalink Pharmaceutical rose 18.3 percent, valuing the company at about $10 billion.